Even in the boardrooms of Pfizer (PFE), they had to have expected President Trump’s Twitter outburst on Monday. If anything, the Pfizer executives set themselves up to be a target.

Let’s look back to the end of May, when Trump promised that some big drug makers would take “voluntary, massive” price cuts in two weeks.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • The most corrupt regime ever has no intention of doing anything that could interfere with the profits of the most corrupt industry ever. Perhaps someone should take a look at how much money Pharma lobbyists spent influencing our elected officials. They wine and dine journalists too, and the effects can be seen in small town newspapers.

  • It appears that drugs are less expensive in Canada. My question is why. Make it legal for American physicians Rx’s to be filled in Canada. How about taxing drug companies the difference between the price of their drugs in Canada or any other country and the cost in the U.S.

    • Drugs are less expensive in Canada because there is essentially only a single payer negotiating drug prices – the Canadian government. This is not how the US market for drugs operates…it could be, but that would require some significant cultural changes.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy